RBM has 20 years’ experience in developing and optimizing multiplex immunoassays and has recently applied the same techniques to the Quanterix Simoa platform, which targets biomarkers expressed at previously un-measureable concentrations. Standard Operating Procedures drive all phases of our processes, from assay development to manufacturing and sample testing. A custom Laboratory Information Management System tracks samples received for testing through the process, from receipt to disposition. Assay results are processed through quality control phases, including controls for instrument function, standard curve integrity, assay performance, and sample testing, to ensure that only quality data is reported. Our proven operational procedures have allowed us to provide unmatched expertise and quality in the field of biomarker testing to support complex clinical research needs.
- 12 Jun 2018
- White Papers